These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10872880)

  • 1. Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates.
    Bailly JE; McAuliffe JM; Skiadopoulos MH; Collins PL; Murphy BR
    Virus Genes; 2000; 20(2):173-82. PubMed ID: 10872880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.
    Bailly JE; McAuliffe JM; Durbin AP; Elkins WR; Collins PL; Murphy BR
    J Virol; 2000 Apr; 74(7):3188-95. PubMed ID: 10708435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic.
    Skiadopoulos MH; Schmidt AC; Riggs JM; Surman SR; Elkins WR; St Claire M; Collins PL; Murphy BR
    J Virol; 2003 Jan; 77(2):1141-8. PubMed ID: 12502830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.
    Schmidt AC; McAuliffe JM; Huang A; Surman SR; Bailly JE; Elkins WR; Collins PL; Murphy BR; Skiadopoulos MH
    J Virol; 2000 Oct; 74(19):8922-9. PubMed ID: 10982335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector.
    Haller AA; Miller T; Mitiku M; Coelingh K
    J Virol; 2000 Dec; 74(24):11626-35. PubMed ID: 11090161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
    Nelson CL; Tang RS; Stillman EA
    Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.
    Skiadopoulos MH; Surman SR; Riggs JM; Collins PL; Murphy BR
    J Virol; 2001 Nov; 75(21):10498-504. PubMed ID: 11581420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid substitution in the viral polymerase creates a temperature-sensitive and attenuated recombinant bovine parainfluenza virus type 3.
    Haller AA; MacPhail M; Mitiku M; Tang RS
    Virology; 2001 Sep; 288(2):342-50. PubMed ID: 11601905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins.
    Suzu S; Sakai Y; Shioda T; Shibuta H
    Nucleic Acids Res; 1987 Apr; 15(7):2945-58. PubMed ID: 3031615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins.
    Sakai Y; Suzu S; Shioda T; Shibuta H
    Nucleic Acids Res; 1987 Apr; 15(7):2927-44. PubMed ID: 3031614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis on the complete genome of a novel caprine parainfluenza virus 3.
    Yang L; Li W; Mao L; Hao F; Wang Z; Zhang W; Deng J; Jiang J
    Infect Genet Evol; 2016 Mar; 38():29-34. PubMed ID: 26631811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.
    Lee MS; Greenberg DP; Yeh SH; Yogev R; Reisinger KS; Ward JI; Blatter MM; Cho I; Holmes SJ; Cordova JM; August MJ; Chen W; Mehta HB; Coelingh KL; Mendelman PM
    J Infect Dis; 2001 Oct; 184(7):909-13. PubMed ID: 11509996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.
    Coelingh KV; Winter CC
    J Virol; 1990 Mar; 64(3):1329-34. PubMed ID: 1689394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
    Durbin AP; McAuliffe JM; Collins PL; Murphy BR
    Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.
    Skiadopoulos MH; Surman SR; Durbin AP; Collins PL; Murphy BR
    Virology; 2000 Jun; 272(1):225-34. PubMed ID: 10873765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.
    Durbin AP; Cho CJ; Elkins WR; Wyatt LS; Moss B; Murphy BR
    J Infect Dis; 1999 Jun; 179(6):1345-51. PubMed ID: 10228053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.
    Durbin AP; Wyatt LS; Siew J; Moss B; Murphy BR
    Vaccine; 1998 Aug; 16(13):1324-30. PubMed ID: 9682397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.